Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

Filter your results:

Types

Topics

105 Results Found

AHA comments to CMS on GLOBE payment model

The AHA commented today on the Centers for Medicare & Medicaid Services’ proposed rule on t
Drug Prices

ASPR announces investment to increase domestic production of essential drugs

The Administration for Strategic Preparedness and Response Feb. 18 announced an investment that will focus on resolving a frequent shortage of oseltamivir, also known as Tamiflu.
Prescription Drugs, Workforce Supply and Demand
Public

Fact Sheet: 340B Drug Pricing Program Contract Pharmacy Arrangements

Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for patients in vulnerable communities. 
340B Drug Pricing Program, Medicaid, Drug Prices

House subcommittee hearing discusses impacts of drug pricing on health care costs 

The House Energy and Commerce Subcommittee on Health today hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain.”
Legislation and Legislative Advocacy, 340B Drug Pricing Program, Prescription Drugs, Commercial Insurer Accountability
Member

DEA and HHS Extend Waivers for Prescribing Controlled Substances Through Telemedicine

The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Dec. 30 released a temporary rule extending for the fourth time waiver flexibilities for prescribing controlled substances via telemedicine.
Telemedicine, Prescription Drugs, Access to Behavioral Health, Opioid Use Disorder, Advocacy & Public Policy, Telehealth
Public

AHA Statement to House E&C Health Subcommittee on Lowering Health Care Costs for All Americans

AHA Statement before the House Committee on Energy and Commerce Health Subcommittee on “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain”
Drug Prices, Prescription Drugs, Access & Health Coverage, Quality & Patient Safety, Supply chain management
Member

House Subcommittee to Host Feb. 11 Hearing with Suppliers as Part of Series Focused on Health Care Affordability

The issue of affordability, including health care affordability, is front and center this year and will be part of this year's congressional and administration discussions, as well as the mid-term elections.
Making Healthcare More Affordable, Prescription Drugs, Drug Prices, Supply chain management
Public

Cost of Caring

This report outlines the key trends impacting hospital financial stability in 2025.
Finance & Budgeting, Cost Management, Workforce, Nurses, Drug Prices, Workforce Supply and Demand, Advocacy & Public Policy, Telling the Hospital Story, Tariffs

TrumpRx platform offers discounted prescription drugs

The White House yesterday launched TrumpRx, the direct-to-consumer platform that will serve as a hub to direct cash-paying consumers to drug manufacturers an
Drug Prices

Department of Labor releases proposed rule on transparency of PBM fee disclosures 

The Department of Labor has issued a proposed rule to improve transparency of fees collected by pharmacy benefit managers.
Drug Price Transparency, Pharmacy